Jefferies Group LLC Vanda Pharmaceuticals Inc. Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $50,059 - $76,427	-4,618 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$15.69 - $21.14 $61,410 - $82,741	3,914 New	3,914 $61,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $72,456 - $97,624	4,618 New	4,618 $66,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $110,722 - $248,018	-14,763 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$12.38 - $17.47 $372,551 - $525,724	-30,093 Reduced 67.09%	14,763 $242,000
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $550,383 - $708,276	44,856 New	44,856 $596,000
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $155,124 - $212,947	-11,120 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $156,236 - $224,624	11,120 New	11,120 $187,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $259M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.